Similar articles

• [HCV-RNA quantity of the serum].

  Sasaki Y, Hige S, Nagasaka A, Matsushima T. Sasaki Y, et al. Nihon Rinsho. 1995 Sep;53 Suppl(Pt 1):965-8. Nihon Rinsho. 1995. PMID: 7563911 Japanese. No abstract available.
• [HCV-RNA of the hepatocytes of the complete responders with disappearance serum HCV-RNA after IFN treatment--using in situ hybridization].

  Terada M. Terada M. Nihon Rinsho. 1995 Sep;53 Suppl(Pt 1):944-8. Nihon Rinsho. 1995. PMID: 7563906 Japanese. No abstract available.
• Hepatitis C and G co-infection: response to interferon therapy and quantitative changes in serum HGV-RNA.

  McHutchison JG, Nainan OV, Alter MJ, Sedghi-Vaziri A, Detmer J, Collins M, Kolberg J. McHutchison JG, et al. Hepatology. 1997 Nov;26(5):1322-7. doi: 10.1002/hep.510260534. Hepatology. 1997. PMID: 9362379 Clinical Trial.
• [Serum HCV-RNA for evaluation of interferon-readministration to the former non responders in chronic hepatitis C].

  Sata M, Tanikawa K. Sata M, et al. Nihon Rinsho. 1994 Jul;52(7):1804-9. Nihon Rinsho. 1994. PMID: 7521422 Review. Japanese.
• Use of virologic assays in the diagnosis and management of hepatitis C virus infection.

  Chevaliez S, Pawlotsky JM. Chevaliez S, et al. Clin Liver Dis. 2005 Aug;9(3):371-82, v. doi: 10.1016/j.cld.2005.05.009. Clin Liver Dis. 2005. PMID: 16023971 Review.